Search

Your search keyword '"Braziel, Rita M."' showing total 491 results

Search Constraints

Start Over You searched for: Author "Braziel, Rita M." Remove constraint Author: "Braziel, Rita M."
491 results on '"Braziel, Rita M."'

Search Results

2. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

3. Supplementary Fig. 3 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

4. Supplementary Fig. 2 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

5. Supplementary Table 2 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

6. Supplementary Fig. 5 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

7. Supplementary Fig. 4 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

8. Supplementary Table 1 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

9. Data from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

10. Supplementary Fig. 1 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms

12. Data from A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

13. CCR Translation for the Article from A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

14. Supplementary Figure 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab

15. CCR Translation for This Article from BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

16. Supplementary Table 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab

17. Supplementary Table 2 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab

18. Supplementary Figure Legends 1-3, Tables 1-3 from BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

19. Supplementary Figures 1-3 from BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

20. Supplementary Data from A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

21. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

22. BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

23. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

24. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

25. B-Cell Lymphomas

27. A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

28. Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

29. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

30. Mutation and Genomic Deletion Status of ataxia telangiectasia mutated (ATM) and p53 Confer Specific Gene Expression Profiles in Mantle Cell Lymphoma

32. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

33. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

35. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

37. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study

38. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

39. Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

40. Expression of vascular endothelial growth factor and its receptors in rosacea

41. Molecular diagnosis of Burkitt's lymphoma

42. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

43. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

44. Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

47. Oncogenically active MYD88 mutations in human lymphoma

49. Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of SWOG S0016

50. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Catalog

Books, media, physical & digital resources